|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of ADMA Biologics (NASDAQ: ADMA) through any online brokerage.
The latest price target for ADMA Biologics (NASDAQ: ADMA) was reported by Raymond James on March 26, 2021. The analyst firm set a price target for 6.00 expecting ADMA to rise to within 12 months (a possible 248.84% upside). 3 analyst firms have reported ratings in the last year.
The stock price for ADMA Biologics (NASDAQ: ADMA) is $1.72 last updated Fri Jun 18 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for ADMA Biologics.
There is no upcoming split for ADMA Biologics.
ADMA Biologics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.